These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 19997956)

  • 21. 2009 pandemic influenza A(H1N1) outbreak in a complex of schools in Paris, France, June 2009.
    Carrillo-Santisteve P; Renard-Dubois S; Cheron G; Csaszar-Goutchkoff M; Lecuit M; Lortholary O; Bello P
    Euro Surveill; 2010 Jun; 15(25):. PubMed ID: 20587360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamic versus static models in cost-effectiveness analyses of anti-viral drug therapy to mitigate an influenza pandemic.
    Lugnér AK; Mylius SD; Wallinga J
    Health Econ; 2010 May; 19(5):518-31. PubMed ID: 19382106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influenza pandemic preparedness in France: modelling the impact of interventions.
    Doyle A; Bonmarin I; Lévy-Bruhl D; Le Strat Y; Desenclos JC
    J Epidemiol Community Health; 2006 May; 60(5):399-404. PubMed ID: 16614329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modelling the health-economic impact of the next influenza pandemic in The Netherlands.
    Hak E; Meijboom MJ; Buskens E
    Vaccine; 2006 Nov; 24(44-46):6756-60. PubMed ID: 16797797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The economic impact of pandemic influenza.
    Maynard A; Bloor K
    BMJ; 2009 Nov; 339():b4888. PubMed ID: 19926698
    [No Abstract]   [Full Text] [Related]  

  • 26. Economic analysis of pandemic influenza vaccination strategies in Singapore.
    Lee VJ; Tok MY; Chow VT; Phua KH; Ooi EE; Tambyah PA; Chen MI
    PLoS One; 2009 Sep; 4(9):e7108. PubMed ID: 19771173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pandemic unpreparedness?
    Nat Rev Microbiol; 2007 Jan; 5(1):2. PubMed ID: 17171851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparing for the next influenza pandemic.
    van Dalen PJ; Wijdenes C
    Neth J Med; 2005 Oct; 63(9):337-8. PubMed ID: 16244379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influenza and the pandemic threat.
    Lee VJ; Fernandez GG; Chen MI; Lye D; Leo YS
    Singapore Med J; 2006 Jun; 47(6):463-70. PubMed ID: 16752013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cost-effectiveness of influenza vaccination for people aged 50 to 64 years: an international model.
    Aballéa S; Chancellor J; Martin M; Wutzler P; Carrat F; Gasparini R; Toniolo-Neto J; Drummond M; Weinstein M
    Value Health; 2007; 10(2):98-116. PubMed ID: 17391419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiviral treatment for outpatient use during an influenza pandemic: a decision tree model of outcomes averted and cost-effectiveness.
    Venkatesan S; Carias C; Biggerstaff M; Campbell AP; Nguyen-Van-Tam JS; Kahn E; Myles PR; Meltzer MI
    J Public Health (Oxf); 2019 Jun; 41(2):379-390. PubMed ID: 29955851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investment decisions in influenza pandemic contingency planning: cost-effectiveness of stockpiling antiviral drugs.
    Lugnér AK; Postma MJ
    Eur J Public Health; 2009 Oct; 19(5):516-20. PubMed ID: 19692550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Economic consequences to society of pandemic H1N1 influenza 2009 - preliminary results for Sweden.
    Brouwers L; Cakici B; Camitz M; Tegnell A; Boman M
    Euro Surveill; 2009 Sep; 14(37):. PubMed ID: 19761738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Economic analysis of pandemic influenza mitigation strategies for five pandemic severity categories.
    Kelso JK; Halder N; Postma MJ; Milne GJ
    BMC Public Health; 2013 Mar; 13():211. PubMed ID: 23496898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Macroeconomic impact of foot-and-mouth disease vaccination strategies for an outbreak in the Midwestern United States: A computable general equilibrium.
    Miller M; Liu L; Shwiff S; Shwiff S
    Transbound Emerg Dis; 2019 Jan; 66(1):156-165. PubMed ID: 30113131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Recommendation of the Royal Academy for Medicine of Belgium to the responsible policy authorities in connection with the continually increasing threat of an outbreak of an influenza epidemic].
    Verh K Acad Geneeskd Belg; 2006; 68(2):139-50. PubMed ID: 16800243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microsimulation of financial impact of demand surge on hospitals: the H1N1 influenza pandemic of fall 2009.
    Braithwaite S; Friedman B; Mutter R; Handrigan M
    Health Serv Res; 2013 Apr; 48(2 Pt 2):735-52. PubMed ID: 23398540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mathematical modeling of the novel influenza A (H1N1) virus and evaluation of the epidemic response strategies in the Republic of Korea].
    Suh M; Lee J; Chi HJ; Kim YK; Kang DY; Hur NW; Ha KH; Lee DH; Kim CS
    J Prev Med Public Health; 2010 Mar; 43(2):109-16. PubMed ID: 20383043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluation.
    Baguelin M; Hoek AJ; Jit M; Flasche S; White PJ; Edmunds WJ
    Vaccine; 2010 Mar; 28(12):2370-84. PubMed ID: 20096762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Economic Costs of Measles Outbreak in the Netherlands, 2013-2014.
    Suijkerbuijk AW; Woudenberg T; Hahné SJ; Nic Lochlainn L; de Melker HE; Ruijs WL; Lugnér AK
    Emerg Infect Dis; 2015 Nov; 21(11):2067-9. PubMed ID: 26488199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.